---
title: "KAGAN BARRY — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0d80bd3b-ea7d-5152-8db7-540243ab0d5d
json: https://whiteintel.dev/api/public/dossier/0d80bd3b-ea7d-5152-8db7-540243ab0d5d
identifier: sec:0001632441
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# KAGAN BARRY

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001632441`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0d80bd3b-ea7d-5152-8db7-540243ab0d5d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0d80bd3b-ea7d-5152-8db7-540243ab0d5d  

## Ownership & control

### Holdings / subsidiaries

- **DIPEXIUM PHARMACEUTICALS, INC.** (director) — https://whiteintel.dev/entity/922c9187-01ca-52f3-9a7a-455b0e76e092

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **KAGAN BARRY**. Human view: https://whiteintel.dev/entity/0d80bd3b-ea7d-5152-8db7-540243ab0d5d · Structured JSON: https://whiteintel.dev/api/public/dossier/0d80bd3b-ea7d-5152-8db7-540243ab0d5d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._